Literature DB >> 21764563

Remission and recovery during the first outpatient year of the early course of schizophrenia.

Joseph Ventura1, Kenneth L Subotnik, Lisa H Guzik, Gerhard S Hellemann, Michael J Gitlin, Rachel C Wood, Keith H Nuechterlein.   

Abstract

BACKGROUND: Although in the early course of schizophrenia relapse prevention is of paramount importance, there is an increasing emphasis on establishing and maintaining sustained periods of symptom remission. Recovery in the early course of illness is also possible, although the rates of recovery are lower than for symptom remission. Symptom remission and recovery rates vary considerably across recent-onset schizophrenia studies because of a lack of consistency in treatment interventions and in applying operational outcome criteria.
METHOD: Patients who were within two years of their first psychotic episode (N=77) that were treated with continuous antipsychotic medication in conjunction with psychosocial interventions (without targeted work rehabilitation) were assessed during the first outpatient year after hospital discharge. Published operational criteria were used to classify symptom remission and recovery.
RESULTS: The rate of full symptom remission maintained for 6 months was 36%, while the rate of recovery for 6 months was 10%. When the same criteria were applied for a continuous period of one year, 22% of patients were found to achieve symptom remission but only 1% of patients met recovery criteria. Using multivariate prediction, the WAIS Comprehension score was a significant predictor of 6 months of good functional outcome.
CONCLUSIONS: Although some schizophrenia patients can achieve both symptom remission and recovery in the early course of illness, the overall rate of symptom remission during the first post-hospitalization year is much higher than the rate of recovery. This suggests that interventions targeting work and social functioning are likely necessary to raise the chances of recovery. Cognitive factors can be predictive of good functional outcome even in the early course of schizophrenia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764563      PMCID: PMC3172347          DOI: 10.1016/j.schres.2011.06.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  56 in total

1.  Longitudinal studies of outcome and recovery in schizophrenia and early intervention: can they make a difference?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Can J Psychiatry       Date:  2005-12       Impact factor: 4.356

2.  Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial.

Authors:  Lone Petersen; Anne Thorup; Johan Øqhlenschlaeger; Torben Øqstergaard Christensen; Pia Jeppesen; Gertrud Krarup; Per Jørrgensen; Erik Lykke Mortensen; Merete Nordentoft
Journal:  Can J Psychiatry       Date:  2008-10       Impact factor: 4.356

3.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

4.  The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.

Authors:  M Tohen; S M Strakowski; C Zarate; J Hennen; A L Stoll; T Suppes; G L Faedda; B M Cohen; P Gebre-Medhin; R J Baldessarini
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

5.  A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis.

Authors:  N M Menezes; A M Malla; R M Norman; S Archie; P Roy; R B Zipursky
Journal:  Acta Psychiatr Scand       Date:  2009-02-05       Impact factor: 6.392

6.  Course of treatment response in first-episode and chronic schizophrenia.

Authors:  S R Szymanski; T D Cannon; F Gallacher; R J Erwin; R E Gur
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

7.  Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

Authors:  K H Nuechterlein; R Parasuraman; Q Jiang
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

8.  Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

Authors:  K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

9.  Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.

Authors:  Pierre Chue
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

10.  IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis.

Authors:  Verity C Leeson; Thomas R E Barnes; Sam B Hutton; Maria A Ron; Eileen M Joyce
Journal:  Schizophr Res       Date:  2008-09-14       Impact factor: 4.939

View more
  25 in total

1.  The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia.

Authors:  Joseph Ventura; Kenneth L Subotnik; Arielle Ered; Denise Gretchen-Doorly; Gerhard S Hellemann; Anja Vaskinn; Keith H Nuechterlein
Journal:  Schizophr Bull       Date:  2014-02-21       Impact factor: 9.306

Review 2.  Relapse risk assessment in early phase psychosis: the search for a reliable and valid tool.

Authors:  Phil Tibbo; Ashok Malla; Rahul Manchanda; Richard Williams; Ridha Joober
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 3.  Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

4.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

5.  Neurocognitive predictors of work outcome in recent-onset schizophrenia.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Michael F Green; Joseph Ventura; Robert F Asarnow; Michael J Gitlin; Cindy M Yee; Denise Gretchen-Doorly; Jim Mintz
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Prediction of functional outcome in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Danielle McLaughlin; Terry E Goldberg; Andrea M Auther; Ruth H Olsen; Doreen M Olvet; Christoph U Correll; Barbara A Cornblatt
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

7.  Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Joseph Ventura; Luana R Turner; Michael J Gitlin; Denise Gretchen-Doorly; Deborah R Becker; Robert E Drake; Charles J Wallace; Robert P Liberman
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

8.  Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.

Authors:  Joseph Ventura; Kenneth L Subotnik; Michael J Gitlin; Denise Gretchen-Doorly; Arielle Ered; Kathleen F Villa; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-12-08       Impact factor: 4.939

9.  Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Authors:  Keith H Nuechterlein; Joseph Ventura; Kenneth L Subotnik; Jacqueline N Hayata; Alice Medalia; Morris D Bell
Journal:  Am J Psychiatr Rehabil       Date:  2014-07

10.  The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Joseph Ventura; Denise Gretchen-Doorly; Gerhard S Hellemann; Elisha R Agee; Laurie R Casaus; John S Luo; Kathleen F Villa; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-08-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.